← FDA Drug Approvals (Drugs@FDA)

TERIFLUNOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOLA PHARMS · Approved 2020-06-17

Drug application

FDA Application #

ANDA209677

Application type

Abbreviated New Drug Application (Generic)

Brand name

TERIFLUNOMIDE

Generic name

Teriflunomide

Active ingredients

TERIFLUNOMIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SOLA PHARMS

First approval

2020-06-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown